Lesch-Nyhan Disease: Clinical Trials

1 trial for Lesch-Nyhan Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Lesch-Nyhan Disease: new trials by email Literature Review of Lesch-Nyhan Disease trials Research Report on Lesch-Nyhan Disease

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease
Ecopipam, Placebo - Lesch-Nyhan Disease, Self-injurious Behavior
Phase 3TerminatedEmalex Biosciences Inc.92012-12-012024-04-22

Narrower conditions

Lesch-Nyhan Syndrome (1)  ·  Self-Injurious Behavior (1)

Broader conditions

Behavior (1)  ·  Behavioral Symptoms (1)  ·  Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Central Nervous System Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Genetic Diseases, X-Linked (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Intellectual Disability (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)

Interventions

ecopipam (1)

Sponsors

Emalex Biosciences Inc. (1)

Countries

Spain (1)  ·  United States (1)

Top investigators

H J Jinnah, MD (1)